Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - Aug 8, 2023
Showing earnings announcements on Aug 08, 2023
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | Super Micro Computer | $18.50B | $0.29 | $1.98B | xxxxxxxxxxxxx | |||||
 | Eli Lilly & Co | $728.85B | $1.98 | $7.58B | xxxxxxxxxxxxx | |||||
 | Rivian Automotive | $14.12B | -$1.43 | $1.02B | xxxxxxxxxxxxx | |||||
 | SoundHound AI, Inc Class A | $8.04B | -$0.12 | $8.07M | xxxxxxxxxxxxx | |||||
 | AMC Entertainment | $1.59B | -$0.36 | $1.29B | xxxxxxxxxxxxx | |||||
 | Marathon Digital Holdings | $6.42B | -$0.06 | $83.44M | xxxxxxxxxxxxx | |||||
 | Twilio | $16.55B | $0.30 | $987.10M | xxxxxxxxxxxxx | |||||
 | Novavax | $1.39B | -$1.33 | $264.16M | xxxxxxxxxxxxx | |||||
 | Li Auto | $23.83B | $0.24 | $3.73B | xxxxxxxxxxxxx | |||||
 | Workhorse Group | $32.92M | -$2.80 | $13.87M | xxxxxxxxxxxxx | |||||
 | United Parcel | $107.25B | $2.49 | $23.04B | xxxxxxxxxxxxx | |||||
 | Datadog | $50.78B | $0.29 | $502.17M | xxxxxxxxxxxxx | |||||
 | Medical Properties | $2.32B | $0.22 | $344.44M | xxxxxxxxxxxxx | |||||
 | Rocket Lab USA | $12.43B | -$0.07 | $61.78M | xxxxxxxxxxxxx | |||||
 | Blink Charging Co | $150.75M | -$0.48 | $23.74M | xxxxxxxxxxxxx | |||||
 | Celsius Holdings | $6.35B | $0.10 | $277.19M | xxxxxxxxxxxxx | |||||
 | Lyft | $5.63B | >-$0.01 | $1.02B | xxxxxxxxxxxxx | |||||
 | Upstart Holdings | $6.24B | -$0.07 | $135.21M | xxxxxxxxxxxxx | |||||
 | Take-Two | $31.96B | $0.34 | $1.22B | xxxxxxxxxxxxx | |||||
 | Luminar Technologies | $176.47M | -$3.44 | $16.18M | xxxxxxxxxxxxx | |||||
 | Duke Energy | $83.64B | $0.98 | $6.16B | xxxxxxxxxxxxx | |||||
 | Digital Turbine | $178.41M | $0.13 | $143.13M | xxxxxxxxxxxxx | |||||
 | Zoetis | $74.37B | $1.31 | $2.16B | xxxxxxxxxxxxx | |||||
 | Clover Health Investments | $1.62B | -$0.14 | $490.82M | xxxxxxxxxxxxx | |||||
 | Iovance Biotherapeutics | $2.25B | -$0.50 | $3.91M | xxxxxxxxxxxxx | |||||
 | Axon Enterprise | $48.17B | $0.62 | $350.55M | xxxxxxxxxxxxx | |||||
 | Bluebird Bio | $82.64M | -$14.10 | $11.30M | xxxxxxxxxxxxx | |||||
 | Hyliion Holdings | $474.30M | -$0.18 | $476.00K | xxxxxxxxxxxxx | |||||
 | Under Armour | $3.55B | -$0.02 | $1.29B | xxxxxxxxxxxxx | |||||
 | Microvision | $215.80M | -$0.10 | $800.00K | xxxxxxxxxxxxx | |||||
 | iRobot | $227.36M | -$1.51 | $214.74M | xxxxxxxxxxxxx | |||||
 | BigBearai Holdings | $779.32M | -$0.06 | $39.31M | xxxxxxxxxxxxx | |||||
 | Castor Maritime | $27.54M | ― | ― | xxxxxxxxxxxxx | |||||
 | Corbus Pharmaceuticals | $158.33M | -$3.10 | ― | xxxxxxxxxxxxx | |||||
 | GrowGeneration | $98.35M | -$0.08 | $64.98M | xxxxxxxxxxxxx | |||||
 | Recursion Pharmaceuticals | $2.36B | -$0.38 | $11.87M | xxxxxxxxxxxxx | |||||
 | Coupang | $41.27B | $0.05 | $5.69B | xxxxxxxxxxxxx | |||||
 | Matterport | $1.53B | -$0.08 | $39.32M | xxxxxxxxxxxxx | |||||
 | Vuzix | $323.91M | -$0.17 | $4.35M | xxxxxxxxxxxxx | |||||
 | Bayer | $19.42B | $0.33 | $13.23B | xxxxxxxxxxxxx | |||||
 | Sangamo Biosciences | $515.36M | -$0.34 | $16.75M | xxxxxxxxxxxxx | |||||
 | Akamai | $14.41B | $1.41 | $930.38M | xxxxxxxxxxxxx | |||||
 | Under Armour | $3.55B | -$0.02 | $1.29B | xxxxxxxxxxxxx | |||||
 | Agenus | $66.39M | -$3.90 | $24.13M | xxxxxxxxxxxxx | |||||
 | NRG Energy | $18.32B | $2.47 | $7.73B | xxxxxxxxxxxxx | |||||
 | NeoGenomics | $2.11B | -$0.11 | $137.45M | xxxxxxxxxxxxx | |||||
 | QuidelOrtho | $3.02B | $0.28 | $615.11M | xxxxxxxxxxxxx | |||||
 | Verastem | $186.48M | -$1.04 | $17.00K | xxxxxxxxxxxxx | |||||
 | DHT Holdings | $1.45B | $0.34 | $109.92M | xxxxxxxxxxxxx | |||||
 | Anavex Life Sciences | $731.79M | -$0.17 | $0.00 | xxxxxxxxxxxxx | |||||
 | Gladstone Commercial | $709.58M | -$0.03 | $36.95M | xxxxxxxxxxxxx | |||||
 | Array Technologies | $855.44M | $0.18 | $448.69M | xxxxxxxxxxxxx | |||||
 | Gilat | $334.12M | $0.02 | $63.84M | xxxxxxxxxxxxx | |||||
 | Vroom | $10.11M | -$40.80 | $225.55M | xxxxxxxxxxxxx | |||||
 | Viridian Therapeutics | $1.51B | -$1.26 | $254.00K | xxxxxxxxxxxxx | |||||
 | Abeona Therapeutics | $247.78M | -$0.67 | $0.00 | xxxxxxxxxxxxx | |||||
 | SmileDirectClub | $80.52K | -$0.11 | $101.90M | xxxxxxxxxxxxx | |||||
 | Beam Therapeutics | $2.40B | -$1.43 | $17.32M | xxxxxxxxxxxxx | |||||
 | 23andMe Holding | $89.38M | -$2.99 | $56.90M | xxxxxxxxxxxxx | |||||
 | PubMatic | $737.52M | -$0.06 | $59.90M | xxxxxxxxxxxxx | |||||
 | Emergent Biosolutions | $438.89M | -$0.65 | $216.17M | xxxxxxxxxxxxx | |||||
 | Nektar Therapeutics | $171.23M | -$0.28 | $21.79M | xxxxxxxxxxxxx | |||||
 | Royalty Pharma | $14.68B | $0.83 | $543.70M | xxxxxxxxxxxxx | |||||
 | Kandi Technologies | $78.62M | ― | ― | xxxxxxxxxxxxx | |||||
 | Cormedix | $520.00M | -$0.24 | $0.00 | xxxxxxxxxxxxx | |||||
 | Masimo | $9.08B | $0.64 | $478.27M | xxxxxxxxxxxxx | |||||
 | Aileron Therapeutics | $37.92M | -$0.40 | $0.00 | ― | xxxxxxxxxxxxx | ||||
 | Bumble | $838.41M | $0.04 | $256.63M | xxxxxxxxxxxxx | |||||
 | Dutch Bros Inc | $8.34B | $0.06 | $253.39M | xxxxxxxxxxxxx | |||||
 | Toast Inc | $21.35B | >-$0.01 | $943.06M | xxxxxxxxxxxxx | |||||
 | Fate Therapeutics | $191.34M | -$0.59 | $5.41M | xxxxxxxxxxxxx | |||||
 | Cerence | $329.72M | -$0.15 | $60.73M | xxxxxxxxxxxxx | |||||
 | Madrigal Pharmaceuticals | $6.73B | -$4.59 | $0.00 | xxxxxxxxxxxxx | |||||
 | Atara Biotherapeutics | $65.66M | -$16.40 | $4.36M | xxxxxxxxxxxxx | |||||
 | Topgolf Callaway Brands | $1.37B | $0.34 | $1.19B | xxxxxxxxxxxxx | |||||
 | Duolingo | $15.05B | -$0.19 | $123.71M | xxxxxxxxxxxxx | |||||
 | Clearway Energy | $5.21B | $0.61 | $375.59M | xxxxxxxxxxxxx | |||||
 | Celldex | $1.67B | -$0.66 | $528.00K | xxxxxxxxxxxxx | |||||
 | Theriva Biologics | $3.17M | -$9.00 | ― | xxxxxxxxxxxxx | |||||
 | Veritone | $88.12M | -$0.26 | $28.06M | xxxxxxxxxxxxx | |||||
 | Macerich | $5.24B | -$0.08 | $205.58M | xxxxxxxxxxxxx | |||||
 | Transdigm Group | $71.76B | $6.38 | $1.69B | xxxxxxxxxxxxx | |||||
 | Adt | $6.19B | $0.06 | $1.65B | xxxxxxxxxxxxx | |||||
 | Seres Therapeutics | $156.31M | $0.53 | $125.67M | xxxxxxxxxxxxx | |||||
 | Ichor Holdings | $1.01B | <$0.01 | $180.03M | xxxxxxxxxxxxx | |||||
 | Rackspace Technology | $512.03M | -$0.08 | $730.44M | xxxxxxxxxxxxx | |||||
 | Aeva Technologies | $216.61M | -$0.69 | $714.00K | xxxxxxxxxxxxx | |||||
 | Syros Pharmaceuticals | $5.37M | -$1.13 | $3.50M | xxxxxxxxxxxxx | |||||
 | Ehealth | $246.55M | -$1.06 | $52.28M | xxxxxxxxxxxxx | |||||
 | BlackLine | $3.96B | $0.29 | $143.98M | xxxxxxxxxxxxx | |||||
 | Amicus | $2.93B | -$0.11 | $89.83M | xxxxxxxxxxxxx | |||||
 | Western Midstream Partners | $14.60B | $0.66 | $795.73M | xxxxxxxxxxxxx | |||||
 | Xeris Pharmaceuticals | $520.29M | -$0.12 | $35.16M | xxxxxxxxxxxxx | |||||
 | Halozyme | $5.97B | $0.63 | $199.95M | xxxxxxxxxxxxx | |||||
 | Jacobs Solutions | $16.84B | $1.52 | $4.07B | xxxxxxxxxxxxx | |||||
 | Infinity Pharmaceuticals | $908.00 | -$0.12 | $700.00K | ― | xxxxxxxxxxxxx | ||||
 | Cipher Mining | $1.99B | -$0.03 | $32.41M | xxxxxxxxxxxxx | |||||
 | Darling Ingredients | $5.26B | $1.58 | $1.83B | xxxxxxxxxxxxx | |||||
 | Organon | $3.75B | $0.97 | $1.57B | xxxxxxxxxxxxx | |||||
 | Powerfleet | $863.21M | -$0.02 | $34.37M | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.